Journal of Nutrition Animal Diets/Enrichment Products...

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vieth, R.
Right arrow Articles by Peltekova, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vieth, R.
Right arrow Articles by Peltekova, V.
(Journal of Nutrition. 2000;130:578-584.)
© 2000 The American Society for Nutritional Sciences


Article

Improved Cholecalciferol Nutrition in Rats Is Noncalcemic, Suppresses Parathyroid Hormone and Increases Responsiveness to 1,25-Dihydroxycholecalciferol1

Reinhold Vieth2, Susan Milojevic and Vanya Peltekova

Departments of Pathobiology and Laboratory Medicine, University of Toronto and Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada

2To whom correspondence should be addressed.

We examined how cholecalciferol (vitamin D) nutrition affected serum 25-hydroxycholecalciferol (25(OH)D) and 1,25-dihydroxycholecalciferol (1,25(OH)2D). Rats were fed conventional diet (vitamin D, 4.5 IU/g, or 7 nmol/d) or the same diet plus 18 nmol/d of extra vitamin D for 3 wk. The extra vitamin D resulted in greater serum 25(OH)D (51 ± 3, vs. control of 21 ± 2 nmol/L), and kidney mRNA for vitamin D receptor [VDR mRNA] (P = 0.026) and lower serum 1,25(OH)2D (72 ± 16 vs. control of 161 ± 10 pmol/L, P = 0.001), and parathyroid hormone (PTH) (89 ± 4 vs. control of 160 ± 15 ng/L, P = 0.001). Kidney VDR mRNA relative to GAPDH mRNA correlated inversely with serum 1,25(OH)2D (r = -0.714, P = 0.006). There were no differences in serum calcium, phosphate, alkaline phosphatase, or weight gain. Experiment 2 compared groups supplemented with 0.2, 2 or 20 nmol/d of vitamin D orally, or 20 nmol/d dermally to see how vitamin D nutrition influenced the response of 1,25(OH)2D to changes in diet calcium. Vitamin D did not affect urinary calcium or pyridinoline excretion, serum calcium, phosphate, vitamin D binding protein or alkaline phosphatase. In groups given 20 nmol/d of vitamin D, renal mitochondrial 25(OH)D-1{alpha}-hydroxylase was lower (P < 0.01) and 25(OH)D-24-hydroxylase was higher (P < 0.05). Higher 25(OH)D concentration was related to proportionally lower 1,25(OH)2D at every calcium intake, indicating greater tissue sensitivity to 1,25(OH)2D. We conclude suppression of 1,25(OH)2D and PTH, and higher renal VDR mRNA and 24-hydroxylase did not involve higher free 1,25(OH)2D concentration or a first pass effect at the gut. Thus, 25(OH)D or a metabolite other than 1,25(OH)2D is a physiological, transcriptionally and biochemically active, noncalcemic vitamin D metabolite.


KEY WORDS: • vitamin D • calcium • adaptation • parathyroid hormone • rats • transcription




This article has been cited by other articles:


Home page
J. Nutr.Home page
J. C. Fleet, C. Gliniak, Z. Zhang, Y. Xue, K. B. Smith, R. McCreedy, and S. A. Adedokun
Serum Metabolite Profiles and Target Tissue Gene Expression Define the Effect of Cholecalciferol Intake on Calcium Metabolism in Rats and Mice
J. Nutr., June 1, 2008; 138(6): 1114 - 1120.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. C. McCann and B. N. Ames
Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?
FASEB J, April 1, 2008; 22(4): 982 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
R. M. Leach Jr. and E. Monsonego-Ornan
Tibial Dyschondroplasia 40 Years Later
Poult. Sci., October 1, 2007; 86(10): 2053 - 2058.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. M Kimball, M. R Ursell, P. O'Connor, and R. Vieth
Safety of vitamin D3 in adults with multiple sclerosis
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 645 - 651.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. A. Tryfonidou, M. A. Oosterlaken-Dijksterhuis, J. A. Mol, T. S. G. A. M. van den Ingh, W. E. van den Brom, and H. A. W. Hazewinkel
24-Hydroxylase: potential key regulator in hypervitaminosis D3 in growing dogs
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E505 - E513.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Vieth, Y. Ladak, and P. G. Walfish
Age-Related Changes in the 25-Hydroxyvitamin D Versus Parathyroid Hormone Relationship Suggest a Different Reason Why Older Adults Require More Vitamin D
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 185 - 191.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Vieth
Vitamin D ingestion and changes to rat aorta
Cardiovasc Res, November 1, 2002; 56(2): 323 - 324.
[Full Text] [PDF]


Home page
J. Nutr.Home page
M. A. Tryfonidou, J. J. Stevenhagen, G.J.C.M. van den Bemd, M. A. Oosterlaken-Dijksterhuis, H. F. DeLuca, J. A. Mol, W. E. van den Brom, J.P.T.M. van Leeuwen, and H.A.W. Hazewinkel
Moderate Cholecalciferol Supplementation Depresses Intestinal Calcium Absorption in Growing Dogs
J. Nutr., September 1, 2002; 132(9): 2644 - 2650.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. Vieth
Reply to FAJ Muskiet et al
Am. J. Clinical Nutrition, December 1, 2001; 74(6): 863 - 864.
[Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]